MedPath

Role of Faecal Calprotectin in Patients With Abdominal Pain

Completed
Conditions
Inflammation
Interventions
Diagnostic Test: calprotectin levels
Registration Number
NCT05795985
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
146
Inclusion Criteria
  • patients with abdominal pain and/or diarrhea and/or rectal bleeding
Read More
Exclusion Criteria
  • patients with age < 18 years
  • pregnant women;
  • patients with oncological, cardiological, nephrological terminal diseases;
  • patients on antibiotic therapy or who have taken it during the last month;
  • patients with a history of colic resection or gastrointestinal surgery;
  • patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis)
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
abdominal paincalprotectin levelspatients with abdominal pain
Primary Outcome Measures
NameTimeMethod
inflammation3 days

assess the degree of intestinal inflammation by fecal calprotectin assay in patients with abdominal pain

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath